Adenovirus Type 4 And Type 7 Vaccine, Live Kit
Product Images NDC 51285-138

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Adenovirus Type 4 And Type 7 Vaccine, Live (NDC 51285-138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Women's Health, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adenovirus Type 4 And Type 7 Vaccine B125296 1

Packaging label for Adenovirus Type 4 and Type 7 Vaccine, Live, oral enteric-coated tablets supplied as a kit. The label identifies the product as containing 100 tablets, intended for oral administration, and lists Teva Women's Health, Inc. as the manufacturer. Dosage and storage instructions are also provided on the label.*

FDA Label Image

Adenovirus Type 4 And Type 7 Vaccine B125296 2

Packaging label for Adenovirus Type 7 Component of Adenovirus Type 4 and Type 7 Vaccine, Live, oral enteric coated tablets by Teva Women's Health, Inc. The label includes dosage instructions for a single oral dose and storage directions. The package contains 100 tablets.*

FDA Label Image

Adenovirus Type 4 And Type 7 Vaccine B125296 3

Packaging label for Adenovirus Type 4 and Type 7 Vaccine, Live, oral dosage form kit by Teva Women's Health, Inc. The label includes storage instructions, dosage information, and package contents indicating 100 doses of the vaccine in coated tablets. The label also features the product NDC 51285-138-50 and barcode.*

FDA Label Image

Adenovirus Type 4 And Type 7 Vaccine B125296 4

Packaging label for Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, consisting of enteric coated tablets for oral administration. The label indicates the vaccine kit contains two components in bottles of 100 tablets each for Adenovirus Type 4 and Type 7. The product is labeled for prescription use only, by Teva Women's Health, Inc., with NDC 51285-138-50.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.